Navigation Links
FDA Accepts Investigational New Drug Application for ARI-3030MO; First in Man Clinical Trial to Begin During First Quarter of 2011
Date:3/21/2011

acy and/or tolerability benefits compared with existing therapies for large markets, whose needs are not being fully met by current therapeutics.  

About Niacin Analog Program

The natural B vitamin niacin is a well known lipid lowering agent and has been used to treat mixed lipid disorders for over 50 years.  Niacin is recommended as a first-line drug for the treatment of hyperlipidemia and it is used in combination with statins to further reduce LDL cholesterol or to increase HDL cholesterol in patients with depressed HDL cholesterol levels.  Niacin can produce changes in HDL cholesterol up to 35%, lower LDL cholesterol up to 25% and lower triglycerides up to 50%.  Despite niacin's broad lipid altering profile, the use of niacin based therapies is diminished because of unpleasant side effects, particularly flushing.  Flushing, representative of tingling and/or redness of the skin, is the principal side effect of niacin and in some patients can be extremely uncomfortable.  Arisaph has developed a novel and proprietary class of structural analogs of niacin that produce compelling changes in lipids without provoking flushing as shown in preclinical pharmacology studies.

Certain statements in this press release, including statements regarding the Company's research and development effort, the Company's expectation to initiate human clinical studies, the Company's ability to finance its development programs into human clinical testing, and the Company's ability to successfully capitalize on the early stage research are subject to risks and uncertainties, which could cause the Company's actual results and the timing of certain events to differ materially from the Company's expectations. These risks and uncertainties include risks and uncertainties related to:  our ability to discover and develop new compounds and products using a novel approach to drug discovery; the early stage of all of ou
'/>"/>

SOURCE Arisaph Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NYSE Amex Accepts China Shenghuos Compliance Plan for Continued Listing
2. The European Medicines Agency Validates and Accepts Cell Therapeutics Marketing Authorization Application for Pixuvri™
3. The SCOOTER Store Accepts Medicare Contracts
4. FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA for Review
5. FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection
6. FDA Accepts Sanofi Pasteurs Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
7. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
8. FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review
9. FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
10. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
11. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging ... China,s orthopedic instrument industry has seen rapid ... from 3.28 billion yuan in 2006 to 9.85 billion ...
(Date:1/15/2014)... Texas , Jan. 15, 2014  Novation, the leading ... awarded several new IT value-added reseller (VAR) national contracts ... IT goods and services at lower costs. These include ... services such as initiative assistance and ongoing IT consulting ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
(Date:7/9/2014)... 8, 2014) Researchers from Montefiore Medical Center ... of Yeshiva University will present new findings at ... 12 July 17 in Copenhagen, Denmark. Data from ... prompt transition from cognitive normality to mild cognitive impairment ... Einstein Aging Study , established in 1980 to examine ...
(Date:7/9/2014)... watching World Cup highlights, Brian Williams refreshing old school ... positions on railings. A University of Colorado Cancer Center ... shows that YouTube also allows researchers, journals, and health ... of skin cancer and prevention. , "No matter what ... how we communicate around the world," says Chante Karimkhani, ...
(Date:7/9/2014)... National Institute of Allergy and Infectious Diseases (NIAID), ... launched an early-stage clinical trial of CRS3123, an ... difficile ( C. difficile ) infection. CRS3123 ... that inhibits C. difficile growth while sparing normal ... enroll up to 30 healthy men and women ...
(Date:7/9/2014)... A retrospective study conducted by researchers at Tufts University ... adults with intellectual and developmental disabilities, the likelihood of ... dental care increased. The findings, published in the July/August ... help improve interventions designed to address the oral health ... reviewed the dental records of 107 patients at one ...
(Date:7/9/2014)... older age with kidney and heart disease have raised ... older adults. However, in the first study to look ... of Medicine at the University of Pennsylvania report that ... life expectancy and cardiovascular health as very healthy older ... of the ever increasing organ transplant waitlists, the authors ...
Breaking Medicine News(10 mins):Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Study of dermatology on YouTube shows new ways science reaches public 2Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3Health News:Penn study finds living kidney donation does not increase risk of death or heart disease for older 2
... natural resource restoration planning process following the BP Deepwater Horizon ... of the Interior (DOI) today announced plans to develop a ... as part of the ongoing Natural Resource Damage Assessment (NRDA). ... scoping meetings in each of the affected Gulf Coast states. ...
... anterior cruciate ligament (ACL) knee reconstruction with a hamstring tendon ... to suffer from pain and mobility issues15 years after surgery, ... Society for Sports Medicine,s Specialty Day in San Diego, California ... results in terms of knee symptoms and function with both ...
... with a mechanical disorder of the hip and can be ... some cases, according to a recent study. The research, conducted ... at the American Orthopedic Society for Sports Medicine 2011 Specialty ... annual meeting of the American Academy of Orthopaedic Surgeons. ...
... Robert Reid realized he gave the same tutorial to ... Was there a way, he wondered, to transform this ... Along with medical student Bryden Magee, Dr. Reid, ... Chair of the Division of Reproductive Endocrinology and Infertility ...
... HealthDay Reporter , FRIDAY, Feb. 18 (HealthDay News) -- Months ... startled to find their artificial joint starts squeaking. Not ... one that squeaks, but those who do are likely to ... new research shows. Fortunately, the squeaks are more of ...
... , FRIDAY, Feb. 18 (HealthDay News) -- Cell ... new British study contends. An analysis of data on ... and 2007 -- when cell phone use was climbing -- ... cancers in men or women, said the University of Manchester ...
Cached Medicine News:Health News:Federal Natural Resource Trustees announce next step in BP Deepwater Horizon spill Gulf restoration 2Health News:Federal Natural Resource Trustees announce next step in BP Deepwater Horizon spill Gulf restoration 3Health News:Hamstring grafts prove more effective in ACL knee reconstruction, study says 2Health News:Common hip disorder can cause sports hernia 2Health News:Common hip disorder can cause sports hernia 3Health News:New educational DVD improves female pelvic exam instruction 2Health News:That Squeaking Sound Might Come From Your New Hip 2Health News:That Squeaking Sound Might Come From Your New Hip 3Health News:British Study Finds No Link Between Cell Phones, Brain Tumors 2
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
Inquire...
Medicine Products: